Intelligent bio solutions inc. achieves major milestone with over 1,000 installed intelligent fingerprinting drug screening readers as of june 30, 2024

New york, aug. 21, 2024 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a leading innovator in non-invasive drug testing technology, today announced the installation of over 1,000 intelligent fingerprinting drug screening readers with customers as of june 30, 2024. this achievement marks a significant milestone for inbs, underscoring the growing demand for the company's advanced drug screening technology.
INBS Ratings Summary
INBS Quant Ranking